\
&
Contact us
\
&
Contact us
Published on | 2 years ago
Programmes MSCAThe MSCA-NET matchmaking platform for Marie Skłodowska-Curie Actions related partner searches is from now on the network’s sole platform for matchmaking. The MSCA-NET Expressions of Interest (EOI) page on the MSCA-NET website is no longer in use (see previous news article).
The matchmaking platform can be found through the MSCA-NET webpage via the EOI button in the top menu bar. The matchmaking platform was launched in May 2022 in order to facilitate matchmaking in the framework of MSCA project and call preparations. The Platform is operational for the 2022, 2023 and 2024 MSCA calls.
All partner searches can be found under the marketplace. All institutions are recommended to include items in the marketplace as project cooperation ideas, expertise or requests. Also, for supervisors it is recommended to include in their marketplace some items as expertise or project ideas in order to attract more fellows. As there is a user limit on the platform, the institutions without a marketplace completed will be deleted in the coming months.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment
The Clean Industrial Deal is described as "a bold business plan to support the competitiveness and resilience of our industry." It aims to boost production in green industries, with special focus on energy-intensive industries - vital for European material production and decarbonization goals. 6 main elements The Deal presents measures to boost e... read more
Security Digital, Industry & Space Digital Europe
In Digital Europe, knowledge of the underlying EU policies and legislations is a key element when drafting a proposal, as they play an important role in the “relevance” evaluation criterion. Also for Horizon Europe Cluster 3 (Cybersecurity) and Cluster 4 (Digital), this knowledge can be handy for applicants. To support... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
